{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T17:44:02Z","timestamp":1761673442017,"version":"build-2065373602"},"reference-count":35,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antibiotics"],"abstract":"<jats:p>Background: Vancomycin-resistant Enterococcus (VRE) has emerged as a major nosocomial pathogen. A recent surveillance of our hospital identified a concerning rise in VRE bacteremia since 2020, despite the stable use of broad-spectrum antibiotics. This trend, coupled with the increased use of daptomycin and linezolid for drug-resistant Gram-positive bacteremia (GPB), prompted an evaluation of their usage beyond approved hospital indications. Methods: A retrospective analysis was carried out from 1 February 2023 to 31 July 2023, during which 100 and 195 patients received linezolid and daptomycin, respectively. Patients\u2019 data were extracted from the hospital\u2019s electronic medical records, and the appropriateness of the antibiotics prescribed was assessed. The amount of daptomycin and linezolid utilization during the study period was also retrieved, as was the incidence of VRE bacteremia. Results: A total of 295 courses of VRE-active agents, linezolid (n = 100) and daptomycin (n = 195), were assessed for appropriateness in this study. Linezolid and daptomycin use were judged as inappropriate 5.0% and 9.2% of the time, respectively. The primary reason for inappropriate linezolid use was overly broad empirical therapy where first-line options like cefazolin and vancomycin could have been prescribed. Daptomycin was often used inappropriately in non-VRE infections, and surgical prophylaxis or use was extended unnecessarily without microbiological justification. Conclusions: Linezolid and daptomycin were prescribed appropriately. Nevertheless, our findings suggest the need to re-evaluate the empirical treatment strategies especially in VRE-colonized patients. Implementation of robust risk-based criteria as well as in-house hospital guidelines or protocols on the initiation of VRE-active agents may help support more judicious prescribing practices of these agents.<\/jats:p>","DOI":"10.3390\/antibiotics14111088","type":"journal-article","created":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T17:02:01Z","timestamp":1761670921000},"page":"1088","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A Retrospective Study on the Use of Daptomycin and Linezolid in Singapore General Hospital"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-5297-784X","authenticated-orcid":false,"given":"Boon San","family":"Teoh","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Singapore General Hospital, Outram Road, Singapore 169608, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi Xin","family":"Liew","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Singapore General Hospital, Outram Road, Singapore 169608, Singapore"},{"name":"Singhealth Duke-NUS Medicine Academic Clinical Programme, 8 College Road, Level 4, Singapore 169857, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yibo","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Singapore General Hospital, Outram Road, Singapore 169608, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5174-7361","authenticated-orcid":false,"given":"Shimin Jasmine","family":"Chung","sequence":"additional","affiliation":[{"name":"Singhealth Duke-NUS Medicine Academic Clinical Programme, 8 College Road, Level 4, Singapore 169857, Singapore"},{"name":"Department of Infectious Diseases, Singapore General Hospital, Outram Road, Singapore 169608, Singapore"},{"name":"Singhealth Duke-NUS Transplant Center, Singapore 169608, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1458-9456","authenticated-orcid":false,"given":"Ban Hock","family":"Tan","sequence":"additional","affiliation":[{"name":"Singhealth Duke-NUS Medicine Academic Clinical Programme, 8 College Road, Level 4, Singapore 169857, Singapore"},{"name":"Department of Infectious Diseases, Singapore General Hospital, Outram Road, Singapore 169608, Singapore"},{"name":"Singhealth Duke-NUS Transplant Center, Singapore 169608, Singapore"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,10,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/nrmicro2761","article-title":"The rise of the Enterococcus: Beyond vancomycin resistance","volume":"10","author":"Arias","year":"2012","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_2","first-page":"1","article-title":"Antimicrobial-resistant pathogens associated with adult healthcare-associated infections: Summary of data reported to the National Healthcare Safety Network, 2015\u20132017","volume":"41","author":"Abner","year":"2020","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1086\/430909","article-title":"Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: A meta-analysis","volume":"41","author":"DiazGranados","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1017\/ice.2015.228","article-title":"VRE and VSE Bacteremia Outcomes in the Era of Effective VRE Therapy: A Systematic Review and Meta-analysis","volume":"37","author":"Prematunge","year":"2016","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1086\/600877","article-title":"Vancomycin therapeutic guidelines: A summary of consensus recommendations from the infectious diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists","volume":"49","author":"Rybak","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Marekovi\u0107, I., Markanovi\u0107, M., Le\u0161in, J., and \u0106ori\u0107, M. (2024). Vancomycin-Resistant Enterococci: Current Understandings of Resistance in Relation to Transmission and Preventive Strategies. Pathogens, 13.","DOI":"10.3390\/pathogens13110966"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/jac\/dkh546","article-title":"Daptomycin: A lipopeptide antibiotic for the treatment of serious Gram-positive infections","volume":"55","author":"Steenbergen","year":"2005","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1093\/jac\/dkg180","article-title":"Pharmacokinetics and tolerance of single- and multiple-dose oral or intravenous linezolid, an oxazolidinone antibiotic, in healthy volunteers","volume":"51","author":"Stalker","year":"2003","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S1473-3099(04)01109-0","article-title":"Peripheral neuropathy associated with prolonged use of linezolid","volume":"4","author":"Bressler","year":"2004","journal-title":"Lancet Infect. Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1093\/jac\/dki476","article-title":"Rhabdomyolysis and acute renal failure in a patient treated with daptomycin","volume":"57","author":"Kazory","year":"2006","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s11096-014-9995-9","article-title":"Antimicrobial stewardship and linezolid","volume":"36","author":"Guillard","year":"2014","journal-title":"Int. J. Clin. Pharm."},{"key":"ref_12","first-page":"282","article-title":"Prescribing trends with daptomycin (cubicin) for the treatment of gram-positive infections","volume":"33","author":"Harnicar","year":"2008","journal-title":"Pharm. Ther."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"ofw246","DOI":"10.1093\/ofid\/ofw246","article-title":"Colonization with Vancomycin-Resistant Enterococci and Risk for Bloodstream Infection Among Patients with Malignancy: A Systematic Review and Meta-Analysis","volume":"4","author":"Alevizakos","year":"2016","journal-title":"Open Forum Infect. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1111\/ajt.12784","article-title":"MRSA and VRE colonization in solid organ transplantation: A meta-analysis of published studies","volume":"14","author":"Ziakas","year":"2014","journal-title":"Am. J. Transplant."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Giamarellou, H., Galani, L., Karavasilis, T., Ioannidis, K., and Karaiskos, I. (2023). Antimicrobial Stewardship in the Hospital Setting: A Narrative Review. Antibiotics, 12.","DOI":"10.3390\/antibiotics12101557"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S1473-3099(16)00065-7","article-title":"Current evidence on hospital antimicrobial stewardship objectives: A systematic review and meta-analysis","volume":"16","author":"Schuts","year":"2016","journal-title":"Lancet Infect. Dis."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Radford-Smith, D.E., and Anthony, D.C. (2025). Vancomycin-Resistant E. faecium: Addressing Global and Clinical Challenges. Antibiotics, 14.","DOI":"10.3390\/antibiotics14050522"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"387","DOI":"10.11622\/smedj.2019088","article-title":"Ten-year narrative review on antimicrobial resistance in Singapore","volume":"60","author":"Chua","year":"2019","journal-title":"Singap. Med. J."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1093\/jac\/dkx492","article-title":"Impact of antibiotic stewardship programmes in Asia: A systematic review and meta-analysis","volume":"73","author":"Lee","year":"2018","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"130","DOI":"10.4103\/0971-5916.164228","article-title":"Antimicrobial stewardship programme (AMSP) practices in India","volume":"142","author":"Walia","year":"2015","journal-title":"Indian J. Med. Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13756-025-01562-1","article-title":"Global knowledge, attitudes, and practices towards antimicrobial resistance among healthcare workers: A systematic review and meta-analysis","volume":"14","author":"Jahromi","year":"2025","journal-title":"Antimicrob. Resist. Infect. Control"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Telli Dizman, G., Metan, G., Zarakolu, P., Tanr\u0131verdi, E.S., Haz\u0131rolan, G., Ayta\u00e7 Ak, H., K\u0131l\u0131n\u00e7arslan, D., Uzun, M., \u00c7elik Kavakl\u0131lar, B., and Ar\u0131k, Z. (2023). Cessation of Rectal Screening for Vancomycin-Resistant Enterococci: Experience from a Tertiary Care Hospital from T\u00fcrkiye. Healthcare, 11.","DOI":"10.3390\/healthcare11192641"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1056\/NEJMoa1808312","article-title":"Partial Oral versus Intravenous Antibiotic Treatment of Endocarditis","volume":"380","author":"Iversen","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"ofaa151","DOI":"10.1093\/ofid\/ofaa151","article-title":"A Narrative Review of Early Oral Stepdown Therapy for the Treatment of Uncomplicated Staphylococcus aureus Bacteremia: Yay or Nay?","volume":"7","author":"Dagher","year":"2020","journal-title":"Open Forum Infect. Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.bbmt.2018.11.008","article-title":"Impact of Empiric Treatment for Vancomycin-Resistant Enterococcus in Colonized Patients Early after Allogeneic Hematopoietic Stem Cell Transplantation","volume":"25","author":"Kamboj","year":"2019","journal-title":"Biol. Blood Marrow Transplant."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"10732748211045593","DOI":"10.1177\/10732748211045593","article-title":"Evaluating Initial Empiric Therapy for Neutropenic Fever in Vancomycin-Resistant En-terococcus-Colonized Patients","volume":"28","author":"Snyder","year":"2021","journal-title":"Cancer Control"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/cpt.726","article-title":"The Nephrotoxicity of Vancomycin","volume":"102","author":"Filippone","year":"2017","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1136\/ejhpharm-2020-002261","article-title":"The potential risk factors of nephrotoxicity during vancomycin therapy in Chinese adult patients","volume":"28","author":"Wang","year":"2021","journal-title":"Eur. J. Hosp. Pharm."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Kan, W.C., Chen, Y.C., Wu, V.C., and Shiao, C.C. (2022). Vancomycin-Associated Acute Kidney Injury: A Narrative Review from Pathophysiology to Clinical Application. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23042052"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e212007","DOI":"10.1001\/jamanetworkopen.2021.2007","article-title":"Assessment of the Appropriateness of Antimicrobial Use in US Hospitals","volume":"4","author":"Magill","year":"2021","journal-title":"JAMA Netw. Open."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"w20135","DOI":"10.4414\/smw.2019.20135","article-title":"Appropriateness of antimicrobial prescribing in a Swiss tertiary care hospital: A repeated point prevalence survey","volume":"149","author":"Erba","year":"2019","journal-title":"Swiss Med. Wkly."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1093\/cid\/cir034","article-title":"Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: Executive summary","volume":"52","author":"Liu","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1128\/AAC.01021-12","article-title":"Treatment duration for uncomplicated Staphylococcus aureus bacteremia to prevent relapse: Analysis of a prospective observational cohort study","volume":"57","author":"Chong","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1161\/CIR.0000000000000296","article-title":"Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications: A Scientific Statement for Healthcare Professionals from the American Heart Association","volume":"132","author":"Baddour","year":"2015","journal-title":"Circulation"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1093\/cid\/civ482","article-title":"2015 Infectious Diseases Society of America (IDSA) Clinical Practice Guidelines for the Diagnosis and Treatment of Native Vertebral Osteomyelitis in Adults","volume":"61","author":"Berbari","year":"2015","journal-title":"Clin. Infect. Dis."}],"container-title":["Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-6382\/14\/11\/1088\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T17:26:41Z","timestamp":1761672401000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-6382\/14\/11\/1088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,28]]},"references-count":35,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["antibiotics14111088"],"URL":"https:\/\/doi.org\/10.3390\/antibiotics14111088","relation":{},"ISSN":["2079-6382"],"issn-type":[{"value":"2079-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,28]]}}}